ABBV

ABBVIE INC. New York Stock Exchange
$152.53
Open: $152.25 High: $155.45 Low: $152.25 Close: $154.74
Range: 2022-06-27 - 2022-06-28
Volume:1,507,360
Market: Open
ABBV
ABBVIE INC. 1 NORTH WAUKEGAN ROAD http://www.abbvieinvestor.com
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
  • CEO: Richard A. Gonzalez
  • Employees: 50,000
  • Sector: Healthcare
  • Industry: Drug Manufacturers
Latest Stocks Posts
Card image
Card image
Card image
ABBV News
Latest news about the ABBV